Ann: India update, page-7

The Company is excited to announce that the Indian Government has approved NovoSorb BTM to be included in the Government-e-Marketplace (GeM) portal.

GeM is a centralised procurement platform for Government hospitals that can now buy NovoSorb BTM throughout India. This approval provides access to supply BTM across all the Defence hospitals, Railways hospitals, ESIC (Employees State Insurance Corporation) hospitals and the various AIIMS (All India Institute of Medical Sciences) hospitals. We expect the first order within a month.

Simultaneously, our India team has been participating in several government tenders which will enable the Company to supply public hospitals.

Sales in private hospitals in India have been growing rapidly on a month-on-month basis.

PolyNovo participated at the National Academy of Burns of India Conference (NABICON) from 15 to 17 February 2024, the flagship event for burn surgeons. This was attended by 180 burn surgeons from all over India. In addition to a PolyNovo sponsored symposium, featuring U.K. surgeon Dr. Pratap Dutta, there were several other presentations featuring NovoSorb BTM by Indian and U.S. surgeons.

Chairman, David Williams said: “Our India team is optimistic we can win a number of other tenders that will open the doors of public hospitals for BTM.”

CEO, Swami Raote said: “It will be a huge step to be able to access burn patients admitted to public hospitals for treatment. NovoSorb BTM will enhance the standard of care and significantly improve the quality of life for Indian patients.”